Diagnosis of intestinal tuberculosis: a systematic review and meta-analysis [0.03%]
肠结核诊断的系统评价和meta分析
Pubet Weeranawin,Tanawat Geeratragool,Wanruchada Katchamart et al.
Pubet Weeranawin et al.
Background/aims: Diagnosis of intestinal tuberculosis (ITB) is challenging. Histopathology and microbiological examination remain the gold standard, but previous studies show varied diagnostic performance. We aimed to sys...
Orofacial granulomatosis in pediatric Crohn's disease: clinical outcomes and genetic background in the era of biologics: a retrospective study in Japan [0.03%]
日本生物制剂时代的儿童克罗恩病口面granulomatosis的临床转归及遗传背景：一项回顾性研究
Ryusuke Nambu,Takeo Naito,Mei Haruyama et al.
Ryusuke Nambu et al.
Background/aims: Occasionally, pediatric Crohn's disease (CD) may develop after diagnosis of orofacial granulomatosis (OFG), which is characterized by chronic granulomatous lesions of the oral mucosa, lips, and perioral a...
The JAK attack: transforming the management of ulcerative colitis in India [0.03%]
JAK阻击：重塑印度溃疡性结肠炎的治疗格局
Arshdeep Singh,Arshia Bhardwaj,Vandana Midha et al.
Arshdeep Singh et al.
Inflammatory bowel disease is increasingly recognized as a significant clinical entity in India, reflecting the country's ongoing epidemiological transition. With a rising incidence and an expanding disease spectrum, the limitations of conv...
Integrating perspectives on transabdominal intestinal ultrasound in inflammatory bowel disease management: a nationwide cross-sectional survey of physicians and patients in China [0.03%]
中国内地医生和炎症性肠病患者经腹肠道超声应用观点的整合：横断面调查研究
Longxi Yun,Zhaojue Wang,Yujun Chen et al.
Longxi Yun et al.
Background/aims: The awareness, accessibility, and utilization of transabdominal intestinal ultrasound (IUS) in inflammatory bowel disease (IBD) management from both physicians' and patients' perspectives remains unclear ...
Population-based screening colonoscopy in Korea: balancing benefits and limitations [0.03%]
韩国基于人群的筛查结肠镜检查：权衡利弊
Hyoung Il Choi,Jae Myung Cha
Hyoung Il Choi
Population-based colonoscopy screening is considered one of the most effective strategies for reducing the incidence and mortality of colorectal cancer. Its major strength lies in its dual benefits: early detection of colorectal cancer and ...
Preventive and therapeutic effects of co-administration of Bacteroides thetaiotaomicron and infliximab on dextran sodium sulfate-induced colitis in mice [0.03%]
拟杆菌和英夫利昔联合用药对葡聚糖硫酸钠诱导的结肠炎小鼠预防及治疗作用
Sara Ahmadi Badi,Hamid Reza Moradi,Ahmad Berimipour et al.
Sara Ahmadi Badi et al.
Background/aims: The gut microbiota plays a crucial role in the pathogenesis and treatment of inflammatory bowel diseases (IBD). This study aimed to investigate the effects of active, heat-inactivated, and cell-free super...
Fecal surrogate markers strongly correlate with endoscopic findings in pediatric onset inflammatory bowel disease: a retrospective study in Japan [0.03%]
日本儿童期起病的炎症性肠病患者粪便生物标志物与内镜表现密切相关：一项回顾性研究
Ryoko Yoshimura,Takahiro Kudo,Masanori Toda et al.
Ryoko Yoshimura et al.
Background/aims: Endoscopy serves as the gold standard for assessing disease activity in inflammatory bowel disease (IBD). Noninvasive biomarkers have been under exploration as potential alternatives. This study aims to e...
Comparison between endoscopic resection and transanal surgery for treatment of rectal tumors: a systematic review and meta‑analysis [0.03%]
内镜切除与经肛手术治疗直肠肿瘤的比较：系统回顾和meta分析
Chan Hyuk Park,Byung Wook Jung,Yoon Suk Jung
Chan Hyuk Park
Background/aims: Both endoscopic resection (ER) and transanal surgery (TAS) are minimally invasive treatment options that allow organ preservation in early rectal tumors. We conducted a meta-analysis to compare treatment ...
Effectiveness, safety, and pharmacokinetics of the infliximab biosimilar CT-P13 after non-medical switch from the infliximab originator in patients with inflammatory bowel disease [0.03%]
从炎症性肠病患者停用原研英夫利西单抗转换为英夫利西单抗生物类似物CT-P13的有效性、安全性和药代动力学：一项多中心、非干预性研究
Ryohei Nomaru,Teruyuki Takeda,Atsushi Takahashi et al.
Ryohei Nomaru et al.
Background/aims: The introduction of anti-tumor necrosis factor-α antibodies transformed the landscape of inflammatory bowel disease (IBD) treatment. Because biologics are associated with increased medical costs, the use...